Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

13
Number of overlapping holdings
33.3%
% of XPH's 39 holdings also in PJP
54.2%
% of PJP's 24 holdings also in XPH
Overlap by Weight
Sector Drift (XPH minus PJP)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in XPH |
Weight in PJP |
Overlap | |
---|---|---|---|---|
ELI LILLY & CO | 5.1% | 6.7% | 5.1% | |
JOHNSON & JOHNSON | 4.8% | 5.7% | 4.8% | |
MERCK & CO. INC. | 4.7% | 6.0% | 4.7% | |
PFIZER INC | 4.5% | 5.2% | 4.5% | |
AMPHASTAR PHARMACEUTICALS INC | 3.4% | 3.9% | 3.4% |
Position Highlights (Non-Overlapping Exposures)
XPH Overweight Relative to PJP
ELANCO ANIMAL HEALTH, INC. | 5.2% | |
INTRA-CELLULAR THERAPIES INC | 5.1% | |
ZOETIS INC | 4.9% | |
ROYALTY PHARMA PLC CLASS A | 4.7% | |
VIATRIS, INC. | 4.7% | |
CATALENT INC | 4.1% | |
BRISTOL-MYERS SQUIBB CO | 4.1% | |
AXSOME THERAPEUTICS, INC. | 3.8% | |
ORGANON & CO. | 3.0% | |
CYMABAY THERAPEUTICS, INC. | 2.6% |
XPH Underweight Relative to PJP
AMGEN INC | -6.4% | |
GILEAD SCIENCES INC | -6.2% | |
ABBOTT LABORATORIES | -6.1% | |
ABBVIE INC | -5.9% | |
UNITED THERAPEUTICS CORP | -3.8% | |
TARO PHARMACEUTICAL INDUS | -3.8% | |
REGENERON PHARMACEUTICALS | -3.6% | |
BIOGEN IDEC INC | -3.3% | |
GERON CORP | -3.2% | |
VALEANT PHARMACEUTICALS INT'L | -3.1% |